FEMINONE (ethinyl estradiol) by Pfizer is ovulation.
Drug data last refreshed 18h ago · AI intelligence enriched Yesterday
FEMINONE is an oral tablet containing ethinyl estradiol, a synthetic estrogen used in hormonal contraception and ovulation suppression. It works by inhibiting the luteinizing hormone (LH) surge necessary for ovulation, thereby preventing conception. This is a pre-launch NDA product sponsored by Pfizer.
Pre-launch stage signals early commercial buildout with roles in launch planning, market access, and field preparation teams.
ovulation.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
Worked on FEMINONE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
This pre-launch product represents a ground-floor opportunity to build brand infrastructure in a legacy therapeutic class with entrenched competition. Career growth depends on launch execution, market penetration strategy, and differentiation narrative versus dozens of existing estrogen-based contraceptives.